01 Apr Histone Therapeutics
Posted at 19:46h
in
Gregory Block, Ph.D., CEO
April 28 | 9:45am | Salone dei Cavalieri, Section 1
Seattle, Washington
(Private)
Histone Therapeutics is a Seattle-based biotechnology company pioneering Gene Activation Therapy through its proprietary eON platform. While traditional genetic medicines focus on tuning “on” genes or silencing overactive ones, Histone targets the ~90% of the genome that is typically “off” in any given cell type. By programming these silent genes, the company aims to restore lost functions, introduce new biological programs, and solve complex diseases associated with chronic disease and aging.